Arkolith/Insider Trading/INM/Form 4/A

Mancini Alexandra Diane Janet

Sr VP, Clinical Reg AffairsInMed Pharmaceuticals Inc. (INM) · full profile →Form 4/A · filed Nov 18, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 14, 2022Disposed to issuer(D)4K—$04K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-22-073945) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML